eMedicine Specialties > Radiology > Brain/Spine

Mesial Temporal Sclerosis

Author: Scott Trepeta, MD, Director of Neuroradiology, Department of Radiology, Jamaica Hospital
Coauthor(s): Stephen Chan, MD, MBA, MPH, Consulting Staff, New York State Psychiatric Institute; Angela Lignelli-Dipple, MD, Assistant Professor of Radiology, Columbia University; Assistant Attending Physician, Department of Radiology, Division of Neuroradiology, Columbia Presbyterian Medical Center
Contributor Information and Disclosures

Updated: Aug 12, 2009

Introduction

Background

Temporal lobe epilepsy is the most common epilepsy syndrome in adults. Seizures usually begin in late childhood or adolescence. Virtually all patients have complex partial seizures, some of which generalize secondarily. In most patients, the epileptogenic focus involves the structures of the mesial temporal lobe. These structures include the hippocampus, amygdala, and parahippocampal gyrus. Antiepileptogenic drugs usually suppress secondary generalized seizures successfully, but 50% of patients or more will continue to have partial seizures. When seizures persist, anterior temporal lobectomy is the treatment of choice.1

Fluid-attenuated inversion recovery (FLAIR) magne...

Fluid-attenuated inversion recovery (FLAIR) magnetic resonance images in a 40-year-old patient with complex partial seizures. The right hippocampus is atrophic and has increased signal intensity that is compatible with mesial temporal sclerosis. Other associated findings of mesial temporal sclerosis are present and are better demonstrated on coronal T2-weighted magnetic resonance images than they are on these images.

Fluid-attenuated inversion recovery (FLAIR) magne...

Fluid-attenuated inversion recovery (FLAIR) magnetic resonance images in a 40-year-old patient with complex partial seizures. The right hippocampus is atrophic and has increased signal intensity that is compatible with mesial temporal sclerosis. Other associated findings of mesial temporal sclerosis are present and are better demonstrated on coronal T2-weighted magnetic resonance images than they are on these images.



Coronal T2-weighted magnetic resonance images dem...

Coronal T2-weighted magnetic resonance images demonstrate mesial temporal sclerosis on the right, as well as associated findings of a small right mammillary body and a small right fornix.

Coronal T2-weighted magnetic resonance images dem...

Coronal T2-weighted magnetic resonance images demonstrate mesial temporal sclerosis on the right, as well as associated findings of a small right mammillary body and a small right fornix.


Recent studies

Chernov et al conducted a retrospective study to evaluate the role of single-voxel proton magnetic resonance spectroscopy (MRS) in preoperative investigation of patients with mesial temporal lobe epilepsy. The authors found that single-voxel proton MRS-detected reduction of N-acetylaspartate content and unilateral presence of lactate in the mesial temporal lobe structures may serve as diagnostic clues for lateralization of the epileptogenic zone in mesial temporal lobe epilepsy. Metabolic imaging was found to have limited usefulness for differentiation of the hippocampal sclerosis and low-grade intra-axial brain tumor. In addition, the presence of significant bilateral metabolic alterations in the mesial temporal lobe structures was associated with worse postoperative seizure control.2

Zijlmans et al compared 3T with 1.5T phased array magnetic resonance imaging (MRI) in the presurgical work-up of patients with epilepsy with complex focus localization. 3T MRI had better interobserver agreement. 3T was found to reveal more dysplasias, while 1.5T revealed more tissue loss and mesial temporal sclerosis. According to the authors, patients can benefit most from 3T scans when a dysplasia is suspected, and they advised reevaluation by another experienced neuroradiologist in cases of negative or equivocal MRIs.3

Provenzale et al confirmed in a study that MRI findings of a markedly hyperintense hippocampus in children with febrile status epilepticus was highly associated with subsequent mesial temporal sclerosis.4

Focke et al explored the integrity of connecting networks using diffusion tensor imaging (DTI) and 2 whole-brain voxel-based methods: statistical parametric mapping (SPM) and tract-based spatial statistics (TBSS). DTI detected extensive changes in mesial temporal lobe epilepsy with hippocampus sclerosis. The affected networks were principally in the ipsilateral temporal lobe and the limbic system, but also in the arcuate fasciculus. SPM and TBSS provided complementary information, with higher sensitivity to fractional anisotropy changes using TBSS.5

Pathophysiology

Mesial temporal sclerosis is the histologic substrate found in approximately 65% of temporal lobectomy specimens obtained in connection with temporal lobe epilepsy, as demonstrated in a study performed by the National Institutes of Health in 1990.6 Mesial temporal sclerosis is the pathologic abnormality most frequently seen in temporal lobe specimens.7

The hippocampus, or intralimbic gyrus, is formed by 2 cortical laminae embedded in each other: the cornu ammonis (CA), also called the hippocampus proper or Ammon horn, and the dentate gyrus. The CA can be divided into regions, or fields, depending on the appearance of pyramidal neurons.

The 4 fields (named by Lorente de No in 1934) are characterized as follows8 :

  • CA1, or the Sommer sector, is the most vulnerable region; it is the most sensitive to hypoxia.
  • CA2 is the most resistant and well-preserved sector.
  • CA3, which enters the concavity of the dentate gyrus, is slightly vulnerable.
  • CA4, sometimes called the endfolium, has intermediate vulnerability to insults.

To embryologic enthusiasts, CA4 is not part of the cornu ammonis but is a separate structure known as the dentate hilus.

The following 3 patterns of cell loss are described in the hippocampus:

  • Classic Ammon horn sclerosis - Primary neuronal loss involves CA1 and CA4; occurs less often in C3 and least often in CA2
  • Total Ammon horn sclerosis - Severe neuronal loss in all of the hippocampal zones, CA1 to CA4
  • Endfolium sclerosis - Cell loss restricted to CA4

These patterns do not suggest clinical significance, and they are not correlated with the severity of seizures or with surgical outcomes. Neuronal loss is accompanied by fibrillary gliosis leading to hippocampal atrophy. In mesial temporal sclerosis, gliosis may also affect the amygdala, uncus, and parahippocampal gyrus.8

Other discrete structural epileptogenic lesions involving mesial temporal structures include hamartomas, gliomas, and vascular malformations. In addition, temporal lobe seizures may begin in an area of neocortex that preferentially projects to mesial temporal structures.

In nearly one third of all temporal lobectomy procedures, dual pathology (for example, a focal lesion and hippocampal sclerosis) is observed. Neuronal counts show mild cell loss when they are associated with a tumor consistent with hippocampal sclerosis as the primary abnormality.

Whether mesial temporal sclerosis is the cause or result of temporal lobe epilepsy is controversial. Some studies have shown a relationship between complex infantile febrile seizure and mesial temporal sclerosis. Patients with complex febrile seizures (duration >15 min, evidence of focal or lateralized convulsive activity, or >3 seizures within 24 h) have an increased incidence of mesial temporal sclerosis. Based on the number of complex features, the incidence of mesial temporal sclerosis in patients who have had complex febrile seizures is 4-50%.9

Frequency

United States

In the United States, epilepsy affects 0.5-1% of the population. Complex partial seizures account for approximately 35% of all cases of epilepsy. Epilepsy is refractory to medical intervention in 15-30% of patients with the condition.

Mortality/Morbidity

Neurologic morbidity from epilepsy can be associated with impaired intelligence and memory. At times, seizures of temporal lobe origin can be confused with a number of psychiatric conditions, such as hypomania or schizophrenia.

Age

Complex partial seizures can occur at any age; however, they demonstrate an increased incidence in adolescence and adulthood. Approximately 55% of all adult seizures are complex partial seizures.

Anatomy

The hippocampal formation is a complex structure that is composed of the CA, subiculum, dentate gyrus, parahippocampal gyrus, fimbria, and fornix. The hippocampal formation is located within the mesial temporal lobe (see Image 1) and protrudes into the medial wall of the temporal horn. Its superior border is the choroidal fissure. The CA is broken into the 4 previously discussed subfields, CA1-CA4.

Diagram of the hippocampal anatomy and adjacent s...

Diagram of the hippocampal anatomy and adjacent structures in the mesial temporal lobe. The cornu ammonis, a part of the hippocampus, can be divided into four fields: CA1, CA2, CA3, and CA4.

Diagram of the hippocampal anatomy and adjacent s...

Diagram of the hippocampal anatomy and adjacent structures in the mesial temporal lobe. The cornu ammonis, a part of the hippocampus, can be divided into four fields: CA1, CA2, CA3, and CA4.



Anatomic diagram depicts the relationship of the ...

Anatomic diagram depicts the relationship of the hippocampus to other structures in the limbic system. Note that the cingulate gyrus is continuous with the parahippocampal gyrus.

Anatomic diagram depicts the relationship of the ...

Anatomic diagram depicts the relationship of the hippocampus to other structures in the limbic system. Note that the cingulate gyrus is continuous with the parahippocampal gyrus.


The hippocampal formation is part of the limbic system (see Image 2), which is believed to represent the anatomic substrate for memory and emotion.

Presentation

Patients with mesial temporal sclerosis usually present with complex partial seizures. Seizures arise in a single region of the brain, the temporal lobe, and they may become generalized secondarily. Because the seizures arise from a single region of the brain, they are termed partial or focal seizures. The term "complex" refers to impaired consciousness, which implies decreased responsiveness and a reduced awareness of self and of one's environment.

Seizures typically last 1-2 minutes; however, the postictal phase of confusion may be prolonged. Most mesial temporal seizures begin with an aura, usually visceral. Examples of auras include an unusual smell (such as that of burning rubber), a feeling of deja vu, a sudden and intense emotional feeling, or a sensory illusion, such as that of objects growing smaller or larger.

Complex partial seizures follow the aura. Typical behaviors include a motionless stare, oral alimentary automatisms (eg, lip smacking, swallowing, chewing, puckering), and upper extremity automatism (eg, fumbling or picking). Complex partial seizures may also be accompanied by the performance of highly skilled activities or a reaction to surroundings that are semiappropriate.

A definitive postictal period of variable duration is noted that may involve aphasia. The patient is usually amnesic for the events that took place during the seizure and may take minutes or hours to recover full consciousness.

When the seizure ends, the patient is usually amnesic for the events that occurred during the seizure, and the person may take minutes or hours to recover full consciousness.10

Preferred Examination

Coronal oblique magnetic resonance imaging (MRI) through the temporal lobes is the preferred modality.

Nuclear medicine scans (positron emission tomography [PET] scans or single-photon emission computed tomography [SPECT] scans) and electroencephalograms (EEGs) also play a role in localization.

Limitations of Techniques

MRI is contraindicated in patients with pacemakers, certain metal prostheses (eg, cochlear implants), or a large number of cerebral aneurysm clips. Metallic foreign bodies within the eyes, as well as shrapnel or bullets when they are located near vascular structures, also are contraindications.

Differential Diagnoses

Other Problems to Be Considered

Other causes of temporal lobe epilepsy, including brain tumors, hamartomas, migrational anomalies, and vascular malformations

More on Mesial Temporal Sclerosis

Overview: Mesial Temporal Sclerosis
Imaging: Mesial Temporal Sclerosis
Multimedia: Mesial Temporal Sclerosis
References
Further Reading

References

  1. Engel J Jr. Mesial temporal lobe epilepsy: what have we learned?. Neuroscientist. Aug 2001;7(4):340-52. [Medline].

  2. Chernov MF, Ochiai T, Ono Y, Muragaki Y, Yamane F, Taira T, et al. Role of proton magnetic resonance spectroscopy in preoperative evaluation of patients with mesial temporal lobe epilepsy. J Neurol Sci. Jul 30 2009;[Medline].

  3. Zijlmans M, de Kort GA, Witkamp TD, Huiskamp GM, Seppenwoolde JH, van Huffelen AC, et al. 3T versus 1.5T phased-array MRI in the presurgical work-up of patients with partial epilepsy of uncertain focus. J Magn Reson Imaging. Aug 2009;30(2):256-62. [Medline].

  4. Provenzale JM, Barboriak DP, VanLandingham K, MacFall J, Delong D, Lewis DV. Hippocampal MRI signal hyperintensity after febrile status epilepticus is predictive of subsequent mesial temporal sclerosis. AJR Am J Roentgenol. Apr 2008;190(4):976-83. [Medline].

  5. Focke NK, Yogarajah M, Bonelli SB, Bartlett PA, Symms MR, Duncan JS. Voxel-based diffusion tensor imaging in patients with mesial temporal lobe epilepsy and hippocampal sclerosis. Neuroimage. Apr 1 2008;40(2):728-37. [Medline].

  6. National Institutes of Health Consensus Conference. Surgery for epilepsy. JAMA. Aug 8 1990;264(6):729-33. [Medline].

  7. Xu S, Pang Q, Liu Y, et al. Neuronal apoptosis in the resected sclerotic hippocampus in patients with mesial temporal lobe epilepsy. J Clin Neurosci. Sep 2007;14(9):835-40. [Medline].

  8. Graham DI, Lantos PL, eds. Greenfield's Neuropathology. 7th ed. London, England: Arnold; 1997:950.

  9. Lewis DV. Febrile convulsions and mesial temporal sclerosis. Curr Opin Neurol. Apr 1999;12(2):197-201. [Medline].

  10. Engel J Jr, Pedley TA. Epilepsy: A Comprehensive Textbook. Philadelphia, Pa: Lippincott-Raven; 1998:517-24, 557-66.

  11. Bronen RA, Fulbright RK, Spencer DD, et al. Refractory epilepsy: comparison of MR imaging, CT, and histopathologic findings in 117 patients. Radiology. Oct 1996;201(1):97-105. [Medline][Full Text].

  12. Chan S, Erickson JK, Yoon SS. Limbic system abnormalities associated with mesial temporal sclerosis: a model of chronic cerebral changes due to seizures. Radiographics. Sep-Oct 1997;17(5):1095-110. [Medline][Full Text].

  13. Lin K, Carrete H, Lin J, et al. Facial paresis in patients with mesial temporal sclerosis: clinical and quantitative MRI-based evidence of widespread disease. Epilepsia. Aug 2007;48(8):1491-9. [Medline].

  14. Jack CR Jr, Rydberg CH, Krecke KN, et al. Mesial temporal sclerosis: diagnosis with fluid-attenuated inversion-recovery versus spin-echo MR imaging. Radiology. May 1996;199(2):367-73. [Medline][Full Text].

  15. Capizzano AA, Vermathen P, Laxer KD, et al. Temporal lobe epilepsy: qualitative reading of 1H MR spectroscopic images for presurgical evaluation. Radiology. Jan 2001;218(1):144-51. [Medline][Full Text].

  16. McBride MC, Bronstein KS, Bennett B, et al. Failure of standard magnetic resonance imaging in patients with refractory temporal lobe epilepsy. Arch Neurol. Mar 1998;55(3):346-8. [Medline][Full Text].

  17. Jackson GD, Berkovic SF, Duncan JS, et al. Optimizing the diagnosis of hippocampal sclerosis using MR imaging. AJNR Am J Neuroradiol. May-Jun 1993;14(3):753-62. [Medline].

  18. Berkovic SF, McIntosh AM, Kalnins RM, et al. Preoperative MRI predicts outcome of temporal lobectomy: an actuarial analysis. Neurology. Jul 1995;45(7):1358-63. [Medline].

Keywords

mesial temporal sclerosis, MTS, hippocampal sclerosis, Ammon horn sclerosis, Ammon's horn sclerosis, complex partial seizures, temporal lobe epilepsy

Contributor Information and Disclosures

Author

Scott Trepeta, MD, Director of Neuroradiology, Department of Radiology, Jamaica Hospital
Scott Trepeta, MD is a member of the following medical societies: American College of Radiology, American Medical Association, American Roentgen Ray Society, and American Society of Neuroradiology
Disclosure: Nothing to disclose.

Coauthor(s)

Stephen Chan, MD, MBA, MPH, Consulting Staff, New York State Psychiatric Institute
Stephen Chan, MD, MBA, MPH is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, American Society of Neuroradiology, Association of University Radiologists, and Radiological Society of North America
Disclosure: Nothing to disclose.

Angela Lignelli-Dipple, MD, Assistant Professor of Radiology, Columbia University; Assistant Attending Physician, Department of Radiology, Division of Neuroradiology, Columbia Presbyterian Medical Center
Disclosure: Nothing to disclose.

Medical Editor

Mahesh R Patel, MD, Chief, MRI, Department of Diagnostic Imaging, Santa Clara Valley Medial Center
Mahesh R Patel, MD is a member of the following medical societies: American Roentgen Ray Society, American Society of Neuroradiology, and Radiological Society of North America
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

L Gill Naul, MD, Professor and Head, Department of Radiology, Texas A&M University College of Medicine; Chair, Department of Radiology, Chief, Section of Magnetic Resonance Imaging, Scott and White Memorial Hospital and Clinic
L Gill Naul, MD is a member of the following medical societies: American College of Radiology, American Medical Association, American Roentgen Ray Society, Radiological Society of North America, and Texas Medical Association
Disclosure: Nothing to disclose.

RELATED EMEDICINE ARTICLES
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.